Vera Therapeutics Inc

Vera Therapeutics insider sales are routine RSU‑based sell‑to‑cover moves; the focus remains on late‑stage trials, pricing, and partnerships to drive future value.

Vera Therapeutics insider buying signals confidence, while recent sell‑to‑cover is routine; track its immunology pipeline and FDA milestones for upside.